Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2022
November
29
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
PreciseDx, Dordrecht Albert Schweitzer Hospital to evaluate cancer risk stratification platform
C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection
KSL Pulse Scientific to distribute Lucira Health COVID, flu molecular test in Canada
Fors Marsh to offer Sera Prognostics preterm birth risk test to employees
Biora Therapeutics, Avero Diagnostics to develop preeclampsia rule-out test
Sherlock Biosciences secures funding to further develop CRISPR testing platform
Sonic Healthcare investing $17.8M to acquire 19.99% of Microba Life Sciences
Page 1 of 1